Patent 12016895 was granted and assigned to Mary Kay Inc. on June, 2024 by the United States Patent and Trademark Office.
A method of treating telangiectasia in a subject in need thereof is disclosed. The method includes topically applying to skin of said subject in need of treatment of telangiectasia a composition comprising effective amounts of an extract of